Show summary Hide summary
A Finnish analysis of medical records suggests subtle health complaints — including mood, balance and headache problems — appear more often in people who go on to receive an early-onset Alzheimer’s diagnosis. The patterns were strongest in the five years before diagnosis, raising the possibility that routine clinical encounters could offer earlier clues to the disease.
How the study was done
Investigators examined nationwide health data for 407 people later diagnosed with early-onset Alzheimer’s (diagnosed under age 65) and compared them with 4,035 matched individuals without the diagnosis. Records covering up to 15 years before the diagnosis date were analyzed to look for differences in medical conditions and health-care usage.
Chad Miller stakes out priorities for Kankakee County Board District 25 ahead of 2026
Mike Tomlin’s Minecraft city sparks massive online buzz: why fans are obsessed
Key findings
The researchers report that several conditions were more frequent among those who later received an early-onset Alzheimer’s diagnosis, and that differences became most marked in the half-decade before diagnosis. The average age at diagnosis in the study population was about 60.
| Condition | People later diagnosed (percent) | Matched controls (percent) |
|---|---|---|
| Vertigo | 5.9% | 2.1% |
| Depression | 5.7% | 2.3% |
| Headache | 4.9% | 1.6% |
| Stroke | 4.4% | 2.0% |
| Alcohol-related disorders | 3.4% | 1.4% |
| Other brain disorders | 2.9% | 0.9% |
| Thyroid disorders | 2.5% | 0.8% |
| Epilepsy | 2.2% | 0.7% |
| Delirium | 1.5% | 0.1% |
| Ear, nose and throat conditions | 5.2% | 2.9% |
In addition to these specific diagnoses, the study observed a notable rise in health-care visits for those who were later diagnosed, particularly in the period immediately before and during the diagnostic process — a pattern that may reflect emerging, non-specific symptoms prompting more clinical contact.
What the authors say
Study co-author Suvi-Johanna Krüger of the University of Oulu emphasized the long preclinical phase of Alzheimer’s, noting that biologic changes start long before cognitive problems become obvious. She and colleagues point out that most prior research has concentrated on late-onset cases, leaving early-onset disease less well characterized.
“Early detection matters because it opens access to treatments and support at a stage when they can be more effective,” Krüger said.
Limitations and caution
The investigation is observational, so it can only show associations rather than establish cause and effect. The authors acknowledge several caveats: they could not independently validate every recorded diagnosis or measure disease severity from the registry data, and other influences — including genetics, lifestyle and socioeconomic status — may have contributed to the observed differences.
Results are drawn from Finnish health records and may not reflect patterns in other countries. The researchers call for larger studies that incorporate biomarkers, genetic testing and structured clinical assessments to determine whether these medical features are genuine risk factors, early symptoms, or coincidental findings.
- Why this matters now: If replicated, these patterns could help clinicians flag patients for earlier cognitive assessment, potentially improving planning and access to care.
- Observational links do not mean causation — more rigorous studies are needed before clinical screening changes are recommended.
- Anyone with persistent or worsening memory, thinking changes, or other unexplained symptoms should consult a health professional.
Published in the journal Alzheimer’s & Dementia, the study adds to a growing body of research seeking to identify signals of Alzheimer’s before clear cognitive decline — a priority as treatments and support systems are more effective when started earlier in the disease course.
